Guiling Li
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 9
- Cancer Cells and Metastasis 3
-
- Ovarian cancer diagnosis and treatment 5
- Co-authors
- Yumeng Wang (8 shared papers)Congjian Xu (4 shared papers)Congjian Xu (9 shared papers)Wei Jiang (1 shared paper)Chong Lu (5 shared papers)Meng Zhang (5 shared papers)Meng Zhang (3 shared papers)Jing Peng (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Ethnopharmacology (3 papers)Gynecologic Oncology (2 papers)Frontiers in Immunology (2 papers)Neuro-Oncology (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Guiling Li
38 papers receiving 544 citations
Peers
Comparison fields: 5 of 70
- Obstetrics and Gynecology 85
- Reproductive Medicine 93
- Oncology 145
- Immunology 105
- Cancer Research 56
Countries citing papers authored by Guiling Li
This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).
Fields of papers citing papers by Guiling Li
This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 69 | |
| 2 | 2022 | 48 | |
| 3 | 2022 | 44 | |
| 4 | 2010 | 43 | |
| 5 | 2019 | 40 | |
| 6 | 2010 | 37 | |
| 7 | 2020 | 34 | |
| 8 | 2021 | 27 | |
| 9 | 2022 | 24 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 20 | |
| 12 | 2021 | 16 | |
| 13 | 2019 | 14 | |
| 14 | 2016 | 14 | |
| 15 | 2022 | 11 | |
| 16 | 2023 | 11 | |
| 17 | 2022 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2017 | 8 |
About Guiling Li
Guiling Li is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 38 papers that have together received 551 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Ovarian cancer diagnosis and treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Cells and Metastasis (3 papers), Endometrial and Cervical Cancer Treatments (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Obstetrics and Gynecology (85 citations), Reproductive Medicine (93 citations), Oncology (145 citations), Immunology (105 citations) and Cancer Research (56 citations). Guiling Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Yumeng Wang, Congjian Xu, Congjian Xu, Wei Jiang, Chong Lu, Wei Jiang, Meng Zhang, Meng Zhang, Jing Peng and Qing Xia. Their work appears in journals such as Journal of Clinical Oncology, Journal of Ethnopharmacology, Gynecologic Oncology, Frontiers in Immunology and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.